Pan S.-T.Wei C.-H.HAN-YUEH KUOHuang R.-Y.Chuang S.-S.2021-08-202021-08-2020131027-8117https://www.scopus.com/inward/record.uri?eid=2-s2.0-84878262742&doi=10.1016%2fj.dsi.2012.10.006&partnerID=40&md5=46985925dec9f8841c0adb3d7e6a3059https://scholars.lib.ntu.edu.tw/handle/123456789/578862[SDGs]SDG2[SDGs]SDG3antibiotic agent; CD20 antigen; cyclophosphamide; doxorubicin; interferon regulatory factor 4; lactate dehydrogenase; prednisolone; protein bcl 6; rituximab; vincristine; aged; anamnesis; antibiotic therapy; bone marrow biopsy; cancer prognosis; cancer recurrence; cancer regression; case report; cell proliferation; cellulitis; erythema; female; heat; histopathology; human; human tissue; lactate dehydrogenase blood level; large cell lymphoma; leg large cell lymphoma; leg pain; leg swelling; letter; lymphocytic infiltration; mitosis; phenotype; skin biopsy; skin discoloration; skin induration; treatment response; tumor biopsyletter10.1016/j.dsi.2012.10.0062-s2.0-84878262742